Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Immuron Limited
< Previous
1
2
Next >
Immuron New U.S. Department of Defense Award & Clinical Trial Update
December 03, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron IMM-529 IND approved by FDA
November 05, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Clinical Trial Update
October 31, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Q1 FY26 YoY growth
October 13, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Submits IMM-529 IND to FDA
October 08, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Letter to Shareholders – Projects Update
October 02, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron partners with InvestorHub
August 26, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron - FY25 global sales exceed projection, up 49% on prior year
July 17, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Letter to Shareholders: Projects Update
May 30, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® highest sales in history
April 10, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
March 05, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® continued strong sales growth
January 17, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
January 15, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Travelan® Clinical Trial Update
January 14, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
December 02, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
November 21, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
October 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® continued strong sales growth
October 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
October 04, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
September 05, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
August 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
August 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron announces record Travelan® sales globally, Australia and USA
July 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron requests pre-IND meeting for IMM-529 with FDA filing
July 02, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
June 05, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore to present at Peak Sky High
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Board Changes
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Limited to Present at the Emerging Growth Conference
May 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Director Resignation
May 03, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
